NYSE: RMAXRe/Max Holdings Inc Stock
$8.04+0.30 (+3.88%)
Updated Jun 18, 2025
RMAX Price
$8.04
Fair Value Price
N/A
Market Cap
$160.28M
52 Week Low
$6.90
52 Week High
$14.31
P/E
17.48x
P/B
0.37x
P/S
0.53x
PEG
0.46x
Dividend Yield
N/A
Revenue
$303.87M
Earnings
$8.52M
Gross Margin
74.4%
Operating Margin
13.8%
Profit Margin
2.8%
Debt to Equity
1.45
Operating Cash Flow
$56M
Beta
1.16
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
RMAX Overview
RE/MAX Holdings, Inc. franchises real estate brokerages and mortgage brokerages, the latter under the Motto Mortgage brand. The company has operates in 110 countries. RE/MAX was founded in 1973 and is headquartered in Denver, CO.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine RMAX's potential to beat the market
BBuy
- Stocks with a Zen Rating of Buy (B) had an average return of +19.88% per year. Learn More
Zen Rating Component Grades
B
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Real Estate Service
Industry Rating
C
RMAX
Ranked#3 of 30
Ranked#3 of 30
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $13.74 | B | |
| $10.40 | B | |
| $11.26 | B |
Be the first to know about important RMAX news, forecast changes, insider trades & much more!
RMAX News
Overview
Due Diligence Score
–
Industry Average (24)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how RMAX scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
RMAX ($8.04) is trading below its intrinsic value of $8.66, according to an updated version of Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
RMAX is good value based on its earnings relative to its share price (17.48x), compared to the US market average (28.67x)
P/E vs Market Valuation
RMAX is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 35 more RMAX due diligence checks available for Premium users.
Valuation
RMAX price to earnings (PE)
For valuing profitable companies with steady earnings
Company
17.48x
Industry
88.25x
Market
28.67x
RMAX is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
RMAX is good value based... subscribe to Premium to read more.
P/E vs Market Valuation
RMAX price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
0.37x
Industry
2.71x
RMAX is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
RMAX price to earnings growth (PEG)
For valuing profitable companies with growth potential
RMAX is good value based... subscribe to Premium to read more.
PEG Value Valuation
RMAX's financial health
Profit margin
Revenue
$74.5M
Net Income
-$2.0M
Profit Margin
-2.6%
RMAX's Earnings (EBIT) of $41.93M... subscribe to Premium to read more.
Interest Coverage Financials
RMAX's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$571.4M
Liabilities
$626.9M
Debt to equity
1.45
RMAX's short-term assets ($214.62M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
RMAX's long-term liabilities ($481.81M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
RMAX's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
RMAX's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$5.7M
Investing
-$1.7M
Financing
-$6.5M
RMAX's operating cash flow ($55.93M)... subscribe to Premium to read more.
Debt Coverage Financials
RMAX vs Real Estate Service Stocks
Re/Max Holdings Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.